New trends in aortic valve surgery

1. Roberts WC. Valvular, subvalvular and supravalvular aortic stenosis: morphologic features. Cardiovasc Clin 1973; 5: 97– 126.

2. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38 (1 Suppl): 61– 67.

3. Brown ML, McKellar SH, Sundt TM et al. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic rewiew and meta‑analysis. J Thorac Cardiovasc Surg 2009; 137: 670– 679.

4. Santana O, Reyna J, Benjo AM et al. Outcomes of minimally invasive valve surgery in patiens with chronic obstructive pulmonary disease. Eur J Cardiothorac Surg 2012; 42: 648– 652.

5. Glauber M, Miceli A, Bevilacqua S et al. Minimally invasive aortic valve replacement via right anterior minithoracotomy: early outcomes and midterm follow‑up. J Thorac Cardiovasc Surg 2011; 142: 1577– 1579.

6. Mokráček A, Čanádyová J, Kurfirst V et al. Bezstehové aortální bio­protézy, první zkušenost s protézou Sorin Perceval S. Interv Akut Kardiol 2013; 12: 121– 123.

7. Lung B, Baron G, Butchart EG et al. A prospective survey of patiens with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 1231– 1243.

8. Brown ML, Pellikka PA, Schaff HV et al. The benefits of early valve replacement in asymptomatic patiens with severe aortic stenosis. J Thorac Cardiovasc Surg 2008; 135: 308– 315.

9. Bouma BJ, van Den Brink RB, van Der Meulen JH et al. To operate or not on eldery patiens with aortic stenosis: the decision and its consequences. Heart 1999; 82: 143– 148.

10. Baraki H, Al Ahmad A, Jeng- Singh S et al. Pacemaker dependancy after isolated aortic valve replacement: do conductance disorders recover over time? Interact Cardiovasc Thorac Surg 2013; 16: 476– 481.

11. Haensig M, Lehmkuhl L, Rastan AJ et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical- aortic valve implantation. Eur J Cardiothorac Surg 2012; 41: 1234– 1240.

12. Osnabrugge RL, Head SJ, Genders TS et al. Costs of transcatether versus surgical aortic valve replacement in intermediate- risk patiens. Ann Thorac Surg 2012; 94: 1954– 1960.

13. Horstkotte D, Schulte H, Bircks W et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291– 301.

14. Clinical communiqué: 16 year results. Carpentier- Edwards Perimount Mitral Pericardial Bioprosthesis. Available from: http:/ / ht.edwards.com/ resourcegallery/ products/ heartvalves/ pdfs/ clinicalcommuniquemitral.pdf.

15. Edwards FH, Peterson ED, Coombs LP et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001; 37: 885– 892.

16. Yap KH, Murphy R, Devbhandari M et al. Aortic valve replacement: is porcine or bovine valve better? Interact Cardiovasc Thorac Surg 2013; 16: 361– 373.

17. Del Rizzo DF, Abdoh A, Cartier P et al. The effect of prosthetic valve type on survival after aortic valve surgery. Semin Thorac Cardiovasc Surg 1999; 11 (4 Suppl 1): 1– 8.

18. Bach DS, Metras J, Doty JR et al. Freedom from structural valve deterioration among patients agend < or = 60 years undergoing Freestyle stentless aortic valve replacement. J Heart Valve Dis 2007; 16: 649– 655.

19. Bach DS, Goldman B, Verrier E et al. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bio­prosthesis. J Heart Valve Dis 2004; 13: 64– 72.

20. Nash PJ, Vitvitsky E, Li J et al. Feasibility of valve repair for regurgitant bicuspid aortic valves –  an echocardiographic study. Ann Thorac Surg 2005; 79: 1473– 1479.

21. Horstkotte D, Piper C. Improvement of oral anticoagulation therapy by INR self- management. J Heart Valve Dis 2004; 13: 335– 338.

22. Sidhu P, O’Kane KO. Self- managed anticoagulation: results from a two‑year prospective randomized trial with heart valve patiens. Ann Thorac Surg 2001; 72: 1523– 1527.

23. Uekermann J, Suchan B, Daum I et al. Neuropsychological deficits after mechanical aortic valve replacement. J Heart Valve Dis 2005; 14: 338– 343.

24. Geiser T, Sturzenegger M, Genewein U et al. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves. Stroke 1998; 29: 1770–1777.

25. Kaps M, Hansen J, Weiher M et al. Clinically silent microemboli in patiens with artificial prosthetic aortic valves are predominantly gaseous and not solid. Stroke 1997; 28: 322– 325.

26. Gencbay M, Degertekin M, Basaran Y et al. Microbubbles associated with mechanical heart valves: their relation with serum lactic dehydrogenace levels. Am Heart J 1999; 137: 463– 468.

27. Skoularigis J, Essop MR, Skudicky D et al. Frequency and severity of intravascular hemolysis after left- sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol 1993; 71: 587– 591.

28. Georgiadis D, Braun S, Uhlmann F et al. Doppler microembolic signals in patients with two different types of bileaflet valves. J Thorac Cardiovasc Surg 2001; 121: 1101–1106.